Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2026-04-15 @ 2:26 PM
Study NCT ID:
NCT06960395
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2025-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Vir Biotechnology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VIR-5525-V101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None